Please Choose

Asset 1

‘If only we had known sooner’

Those words, uttered silently by physicians every day, is the reason Sivan exists.

The frustration of discovering a problem too late to treat effectively. The blow to a patient when they learn that little can be done for them now. The inability of hospitals to provide the monitoring required to detect problems early, at scale.

It’s a scenario that repeats itself in health centers every day - and it’s almost entirely avoidable. The solution lies in a radical new approach to capturing and processing patient reported outcomes (PRO).

Who we are, and what we do

We are a multidisciplinary team of clinicians, technologists and behavioural experts who have come together to solve some of the biggest challenges in healthcare.

Building on multi-year clinical studies on the impact of patient reported symptoms on survival and quality of life, carried out by leading oncologists in the US and France, we have developed the first digital platform for the early detection of disease.


We’re on a mission

to improve patient survival

Dr. Ethan Basch
The future of cancer care lies in electronic symptom monitoring. The benefits of this approach are better than many cancer drugs.
Dr. Alain Livartowski
Moovcare® has been warmly received by patients - due to the ease of use, the short time spent responding to the questionnaires, and the feeling of being in constant touch with the medical team.
Asset 2

Our partners

Product pipeline

Moovcare® is the first in a line of breakthrough digital therapeutics developed by Sivan in collaboration with leading oncologists. All devices monitor symptoms using web-based patient reported outcomes (PROs), which the company’s clinically proven algorithms analyze to detect early signs of relapse, complication, or future medical risk.
Moovcare® Lung
ID of high risk populations
Other chronic diseases
Moovcare® AllCancer
Companion application